Anup Radhakrishnan

Anup Radhakrishnan has a diverse work experience spanning various finance and leadership roles. Anup most recently served as the Chief Financial Officer at CARGO Therapeutics since August 2022. Prior to that, they were the Chief Financial Officer at Dascena, now known as CirrusDx, from April 2021 to August 2022. Anup also held the Vice President, Finance position at Dascena from July 2021 to April 2021.

Anup's extensive experience includes working at Genentech, where they held several senior finance director and manager roles. Anup served as the Sr. Finance Director, Head of Access and External Affairs Finance from January 2020 to April 2021. Before that, they served as the Finance Lead for the US Breast and Skin Cancer Franchise from June 2018 to April 2021.

At Genentech, Anup also held the roles of Finance Director, Head of Managed Care and Customer Operations Finance from July 2016 to January 2020, Associate Finance Director, Commercial Finance from May 2014 to July 2016, Sr. Finance Manager, Commercial Finance Decision Support from October 2011 to May 2014, and Finance Manager, Commercial Finance Decision Support from January 2010 to October 2011.

In addition to their time at Genentech, Anup served as the Chief Financial Officer at Genentech Patient Foundation from July 2016 to April 2021. Anup also gained experience in the pharmaceutical industry as the Head of R&D Finance at Elan Pharmaceuticals from October 2006 to January 2010.

Anup began their career as a Financial Analyst, FP&A at CV Therapeutics, which was later acquired by Gilead, from September 2005 to October 2006. Prior to that, they worked as a Strategic Sourcing Manager at UCSF, Ernest Gallo Clinic and Research Center from February 2002 to September 2005. Anup started their career as a Cost Accountant, Brita FP&A at The Clorox Company from July 2001 to December 2001.

Overall, Anup Radhakrishnan has a wealth of experience in finance and leadership roles, including CFO positions at multiple organizations and various roles at Genentech.

Anup Radhakrishnan completed their Bachelor's degree in Finance at the University of San Francisco from 1997 to 2001.